Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/regulus-therapeutics-reports-fourth-quarter-and-year-end-2023-financial-results-and-recent-updates-302096347.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-positive-topline-data-from-the-second-cohort-of-patients-in-its-phase-1b-multiple-ascending-dose-mad-clinical-trial-of-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-ad-302086081.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-completion-of-enrollment-in-third-cohort-of-phase-1b-multiple-ascending-dose-mad-clinical-trial-of-rgls8429-for-the-treatment-of-patients-with-autosomal-dominant-polycystic-kidney-disease-adpkd-302024791.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-reports-third-quarter-2023-financial-results-and-recent-updates-301980843.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-first-patient-dosed-in-third-cohort-of-phase-1b-multiple-ascending-dose-mad-clinical-trial-of-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-301974764.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-advances-to-cohort-3-of-phase-1b-multiple-ascending-dose-mad-clinical-trial-of-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-301961375.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-positive-topline-data-from-the-first-cohort-of-patients-in-its-phase-1b-multiple-ascending-dose-mad-clinical-trial-of-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adp-301932766.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-completion-of-enrollment-in-second-cohort-of-phase-1b-multiple-ascending-dose-mad-clinical-trial-of-rgls8429-for-the-treatment-of-patients-with-autosomal-dominant-polycystic-kidney-disease-adpkd-301925276.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-participation-at-two-healthcare-investment-conferences-301915001.html
https://www.prnewswire.com/news-releases/regulus-therapeutics-to-host-virtual-investor-event-on-september-6-2023-301907404.html